Sialic acid content of LDL in coronary artery disease: No evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: Relation between desialylation and in vitro peroxidation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 6, 1998, Pages 876-883

  Chappey, B ^a,b   Beyssen, B ^b   Foos, E ^b   Ledru, F ^b   Guermonprez, J L ^b   Gaux, J C ^b   Myara, I ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Angiography; Coronary artery disease; Low density lipoprotein; Peroxidation; Sialic acid

Indexed keywords

LOW DENSITY LIPOPROTEIN; SIALIC ACID;

ACUTE HEART INFARCTION; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIALYLATION;

EID: 0031776084     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.6.876     Document Type: Article

References (20)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham study. Ann Intern Med. 1971;74:1-12.
2. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA. 1986;256:334-339.
3. Shen MMS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 1981;22:236-244.
4. Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res. 1988;29:442-458.
5. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins: characterization of apoA- and apoB-containing lipoprotein families. Prog Lipid Res. 1991;30:105-138.
6. Chappey B, Myara I, Benoit MO, Mazière C, Mazière JC, Moatti N. Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL): no evidence of peroxidative modifications. Biochim Biophys Acta. 1995;1259:261-270.
7. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res. 1991;32:1741-1753.
8. de Graaf J, Hendriks JCM, Demacker PNM, Stalenhoef AFH. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Arterioscler Thromb. 1993;13:712-719.
9. Austin MA, King MC, Vranizan KM, Krauss RM. The atherogenic lipoprotein phenotype (ALP): a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
10. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particles size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
11. Taniguchi T, Ishikawa Y, Tsunemitsu M, Fukuzaki H. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Arch Biochem Biophys. 1989;273:197-205.
12. Senn HJ, Orth M, Fitzke E, Wieland H, Gerok W. Gangliosides in normal human serum: concentration, pattern and transport by lipoproteins. Eur J Biochem. 1989;181:657-662.
13. La Belle M, Krauss RM. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res. 1990;31:1577-1588.
14. Tertov VV, Orekhov AN, Sobenin IA, Morriset JD, Gotto AM Jr, Guevara JG Jr. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res. 1993;34:365-375.
15. Filipovic I, Schwarzmann G, Mraz W, Wiegandt H, Buddecke E. Sialic acid content of low-density lipoproteins controls their binding and uptake by cultured cells. Eur J Biochem. 1979;93:51-55.
16. Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun. 1989;162:206-211.
17. Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP, Guevara JG Jr, Gotto AM Jr, Morriset JD. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res. 1992;33:805-817.
18. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 1985;55:93-105.
19. Dousset N, Dousset JC, Taus M, Ferretti G, Curatola G, Soléra ML, Valdiguié P. Effect of desialylation on low density lipoprotein: comparative study before and after oxidative stress. Biochem Mol Biol Int. 1994;32:555-563.
20. Myara I, Haberland ME, Demuth K, Chappey B, Moatti N. Susceptibility to copper oxidation of neuraminidase-treated LDL. Clin Chim Acta. 1995;240:221-223.